The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Gartmore gets more alternative

Hedge funds

Glyn Jones

Gartmore is increasing its slant towards hedge funds with the acquisition of Riverview International Group in the US. Riverview is a specialist hedge fund of funds business in New Jersey. Gartmore has bought out 100% of the business but will not say for how much.

The acquisition follows on from Gartmore's increasing concentration on alternative investments since 1999 when it launched its first hedge fund, the AlphaGen Capella, under Roger Guy.

The AlphaGen umbrella now has seven funds with $2 billion in assets under management. This figure is still a small share of its overall assets of £53 billion but the Riverview acquisition shows where Gartmore sees its future. This is quite a reinvention from the mid to late 1990s when it put a lot of effort into passive management as its traditional institutional business struggled to produce strong returns.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree